HSA issues advisory for two products with undeclared medicinal ingredients

The Health Sciences Authority (HSA) has issued an advisory to alert members of the public about two products containing undeclared medicinal ingredients. The two products are Montalin Jamu Pegal Linu Dan Asam Urat and orange capsules called Bai He Bao Jian Su.

Users of Montalin, a supposed pain reliever, are advised to stop taking them immediately. Investigations and testing by HSA showed undeclared medicines such as piroxicam and paracetamol present in the product samples.

Those who have taken Bai He Bao Jian Su, purportedly to treat various skin conditions, are advised to consult a doctor before stopping their intake. The latter contains steroids and sudden discontinuation without proper medical advice could lead to withdrawal symptoms such as fatigue and low blood pressure, the statement said.

HSA added that complementary health products are not allowed to contain western medicinal ingredients or substances controlled under the Poisons Act or Health Products Act.

Anyone found convicted of selling these illegal products will face a penalty fine of up to $10,000 and/or imprisonment for a period of up to two years under the Poisons Act. They may also face a penalty fine of up to $100,000 and/or imprisonment for up to three years under the Health Products Act.

Members of the public with information on the two products can contact HSA's enforcement branch at 6866-3485 during office hours or e-mail hsa_is@hsa.gov.sg